NCT06730906

PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise

Testing and Refinement of PACTAID App in Patients With Type 1 Diabetes to Help Manage Exercise While on Automated Insulin Delivery System

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this trial is to test and refine the PACTAID smart phone application in adults with type 1 diabetes mellitus to help manage exercise while on automated insulin delivery systems with the goal of improving glycemic control during and after exercise as well as improving multiple other cardiovascular risk factors.

Detailed description

This trial will be conducted in two phases. In Phase 1, we will test the PACTAID app in adults with type 1 diabetes mellitus to help manage exercise while on an automated insulin delivery system for four weeks. In phase 2, we will use a refined version of the PACTAID app in those same adults from phase 1 for four weeks. A 2-4-week period will be between phase 1 and phase 2 in which the app will be refined. There is one clinical site, Mayo Clinic, and two sites creating the app, Arizona State University and University of Houston. The study will enroll up to 8 subjects at Mayo Clinic.

Conditions

• Type 1 Diabetes Mellitus

Interventions

Type	Name	Description
DEVICE	PACTAID App	The PACTAID app will provide real time decision support during exercise for patients with type 1 diabetes.

Timeline

• Start date: 2025-01-10
• Primary completion: 2026-03-31
• Completion: 2026-12-31
• First posted: 2024-12-12
• Last updated: 2026-01-07

Locations

1 site across 1 country: United States